41 results on '"Palm, O."'
Search Results
2. Efficacy and safety of a novel synergistic drug candidate, CRx-102 in hand osteoarthritis
- Author
-
Kvien, T.K., Fjeld, E., Slatkowsky-Christensen, B., Nichols, M., Zhang, Y., Proven, A., Mikkelsen, K., Palm, O., Borisy, A.A., and Lessem, J.
- Subjects
Osteoarthritis -- Drug therapy ,Antiarthritic agents -- Dosage and administration ,Antiarthritic agents -- Research ,Hand -- Diseases ,Health - Published
- 2008
3. Management and Environmental Constraints to Rice Yield within a Village Irrigation System — A Case Study from Sri Lanka
- Author
-
Daléus, E., Palm, O., Sandell, K., Jayawardena, S. N., and Siripala, G. D.
- Published
- 1988
4. Nachweis des Gummiholz-Virus (Rubbery wood) in Apfelbäumen mit Hilfe der elektrischen Leitfähigkeitsmessung (Vorläufige Mitteilung)
- Author
-
Liebster, G., Palm, O., and Schmid, P.
- Published
- 1968
5. On the Composition of Petroleum
- Author
-
Mabery, Charles F., Palm, O. R., and Sieplein, Otto J.
- Published
- 1904
- Full Text
- View/download PDF
6. A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility
- Author
-
David Carmona, F, Mackie, SL, Martin, J-E, Taylor, JC, Vaglio, A, Eyre, S, Bossini-Castillo, L, Castaneda, S, Cid, MC, Hernandez-Rodriguez, J, Prieto-Gonzalez, S, Solans, R, Ramentol-Sintas, M, Francisca Gonzalez-Escribano, M, Ortiz-Fernandez, L, Morado, IC, Narvaez, J, Miranda-Filloy, JA, Beretta, L, Lunardi, C, Cimmino, MA, Gianfreda, D, Santilli, D, Ramirez, GA, Soriano, A, Muratore, F, Pazzola, G, Addimanda, O, Wijmenga, C, Witte, T, Schirmer, JH, Moosig, F, Schoenau, V, Franke, A, Palm, O, Molberg, O, Diamantopoulos, AP, Carette, S, Cuthbertson, D, Forbess, LJ, Hoffman, GS, Khalidi, NA, Koening, CL, Langford, CA, McAlear, CA, Moreland, L, Monach, PA, Pagnoux, C, Seo, P, Spiera, R, Sreih, AG, Warrington, KJ, Ytterberg, SR, Gregersen, PK, Pease, CT, Gough, A, Green, M, Hordon, L, Jarrett, S, Watts, R, Levy, S, Patel, Y, Kamath, S, Dasgupta, B, Worthington, J, Koeleman, BPC, de Bakker, PIW, Barrett, JH, Salvarani, C, Merkel, PA, Gonzalez-Gay, MA, Morgan, AW, Martin, J, Carmona, F. David, Mackie, Sarah L., Martín, Jose-Ezequiel, Taylor, John C., Vaglio, Augusto, Eyre, Stephen, Bossini-Castillo, Lara, Castañeda, Santo, Cid, Maria C., Hernández-Rodríguez, José, Prieto-González, Sergio, Solans, Roser, Ramentol-Sintas, Marc, González-Escribano, M. Francisca, Ortiz-Fernández, Lourde, Morado, Inmaculada C., Narváez, Javier, Miranda-Filloy, José A., Beretta, Lorenzo, Lunardi, Claudio, Cimmino, Marco A., Gianfreda, Davide, Santilli, Daniele, Ramirez, Giuseppe A., Soriano, Alessandra, Muratore, Francesco, Pazzola, Giulia, Addimanda, Olga, Wijmenga, Cisca, Witte, Torsten, Schirmer, Jan H., Moosig, Frank, Schönau, Verena, Franke, Andre, Palm, Oyvind, Molberg, Oyvind, Diamantopoulos, Andreas P., Carette, Simon, Cuthbertson, David, Forbess, Lindsy J., Hoffman, Gary S., Khalidi, Nader A., Koening, Curry L., Langford, Carol A., Mcalear, Carol A., Moreland, Larry, Monach, Paul A., Pagnoux, Christian, Seo, Philip, Spiera, Robert, Sreih, Antoine G., Warrington, Kenneth J., Ytterberg, Steven R., Gregersen, Peter K., Pease, Colin T., Gough, Andrew, Green, Michael, Hordon, Lesley, Jarrett, Stephen, Watts, Richard, Levy, Sarah, Patel, Yusuf, Kamath, Sanjeet, Dasgupta, Bhaskar, Worthington, Jane, Koeleman, Bobby P.C., De Bakker, Paul I.W., Barrett, Jennifer H., Salvarani, Carlo, Merkel, Peter A., González-Gay, Miguel A., Morgan, Ann W., and Martín, Javier
- Subjects
Multifactorial Inheritance ,Genotype ,European Continental Ancestry Group ,Genes, MHC Class II ,Giant Cell Arteritis ,Genetic Association Studie ,Article ,White People ,MHC Class II ,Cohort Studies ,Genetic ,Genes ,Genetic Association Studies ,Humans ,Multivariate Analysis ,Odds Ratio ,Genetics ,Genetics(clinical) ,Cohort Studie ,Multivariate Analysi ,Giant Cell Arteriti ,Genetics (clinical) ,Human - Abstract
We conducted a large-scale genetic analysis on giant cell arteritis (GCA), a polygenic immune-mediated vasculitis. A case-control cohort, comprising 1,651 case subjects with GCA and 15,306 unrelated control subjects from six different countries of European ancestry, was genotyped by the Immunochip array. We also imputed HLA data with a previously validated imputation method to perform a more comprehensive analysis of this genomic region. The strongest association signals were observed in the HLA region, with rs477515 representing the highest peak (p = 4.05 × 10(-40), OR = 1.73). A multivariate model including class II amino acids of HLA-DRβ1 and HLA-DQα1 and one class I amino acid of HLA-B explained most of the HLA association with GCA, consistent with previously reported associations of classical HLA alleles like HLA-DRB1(∗)04. An omnibus test on polymorphic amino acid positions highlighted DRβ1 13 (p = 4.08 × 10(-43)) and HLA-DQα1 47 (p = 4.02 × 10(-46)), 56, and 76 (both p = 1.84 × 10(-45)) as relevant positions for disease susceptibility. Outside the HLA region, the most significant loci included PTPN22 (rs2476601, p = 1.73 × 10(-6), OR = 1.38), LRRC32 (rs10160518, p = 4.39 × 10(-6), OR = 1.20), and REL (rs115674477, p = 1.10 × 10(-5), OR = 1.63). Our study provides evidence of a strong contribution of HLA class I and II molecules to susceptibility to GCA. In the non-HLA region, we confirmed a key role for the functional PTPN22 rs2476601 variant and proposed other putative risk loci for GCA involved in Th1, Th17, and Treg cell function.
- Published
- 2015
7. The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis
- Author
-
Martin, J.E., Carmona, F.D., Broen, J.C.A., Simeon, C.P., Vonk, M.C., Carreira, P., Rios-Fernandez, R., Espinosa, G., Vicente-Rabaneda, E., Tolosa, C., Garcia-Hernandez, F.J., Castellvi, I., Fonollosa, V., Gonzalez-Gay, M.A., Saez-Comet, L., Portales, R.G., Pena, P.G. de la, Fernandez-Castro, M., Diaz, B., Martinez-Estupinan, L., Coenen, M., Voskuyl, A.E., Schuerwegh, A.J., Vanthuyne, M., Houssiau, F., Smith, V., Keyser, F. de, Langhe, E. de, Riemekasten, G., Witte, T., Hunzelmann, N., Kreuter, A., Palm, O., Chee, M.M., Laar, J.M. van, Denton, C., Herrick, A., Worthington, J., Koeleman, B.P.C., Radstake, T.R.D.J., Fonseca, C., Martin, J., Spanish Scleroderma Grp, Rheumatology, and CCA - Innovative therapy
- Subjects
Adult ,Interleukin 2 ,systemic sclerosis ,Immunology ,PATHOGENESIS ,BETA ,Genome-wide association study ,Locus (genetics) ,Biology ,Polymorphism, Single Nucleotide ,anti-centromere auto-antibody ,CLASSIFICATION ,Autoimmune Diseases ,Immune tolerance ,Pathogenesis ,INTERLEUKIN-2-RECEPTOR ,SCLERODERMA ,rs12722495 ,Genetics ,medicine ,Medicine and Health Sciences ,Humans ,REGULATORY T-CELLS ,Allele ,GENOME-WIDE ASSOCIATION ,skin and connective tissue diseases ,Genomic disorders and inherited multi-system disorders Molecular epidemiology [IGMD 3] ,Genetics (clinical) ,Autoimmune disease ,Scleroderma, Systemic ,IL2RA ,rs2104286 ,Interleukin-2 Receptor alpha Subunit ,Odds ratio ,Middle Aged ,medicine.disease ,Infection and autoimmunity Auto-immunity, transplantation and immunotherapy [NCMLS 1] ,Genetic Loci ,rs11594656 ,Evaluation of complex medical interventions Auto-immunity, transplantation and immunotherapy [NCEBP 2] ,medicine.drug - Abstract
Contains fulltext : 109760.pdf (Publisher’s version ) (Closed access) Regulatory T cells (T(regs)) are crucial in the maintenance of the immune tolerance and seem to have an important role in systemic sclerosis (SSc). The interleukin 2 receptor alpha (IL2RA) is an important T(reg) marker, and polymorphisms of IL2RA gene are associated with a number of autoimmune diseases. Therefore, we aimed to investigate for the first time the association of the IL2RA locus in SSc. For this purpose, a total of 3023 SSc patients and 2735 matched healthy controls, from six European Caucasian cohorts, were genotyped for the IL2RA gene variants rs11594656, rs2104286 and rs12722495 using the TaqMan allelic discrimination technology. The overall meta-analysis reached statistical significance when the three polymorphisms were tested for association with SSc, the limited subtype (lcSSc) and anti-centromere auto-antibodies (ACAs). However, no significant P-values were obtained when the ACA-positive patients were removed from the SSc and lcSSc groups, suggesting that these associations rely on ACA positivity. The strongest association signal with ACA production was detected for rs2104286 (P(FDR)=2.07 x 10(-4), odds ratio=1.30 (1.14-1.47)). The associations of rs11594656 and rs12722495 were lost after conditioning to rs2104286, and allelic combination tests did not evidence a combined effect, indicating that rs2104286 best described the association between IL2RA and ACA presence in SSc. 01 februari 2012
- Published
- 2012
- Full Text
- View/download PDF
8. A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations
- Author
-
Bossini-Castillo, L., Martin, J.E., Broen, J., Gorlova, O., Simeon, C.P., Beretta, L., Vonk, M.C., Callejas, J.L., Castellvi, I., Carreira, P., Garcia-Hernandez, F.J., Castro, M.F., Coenen, M.J.H., Riemekasten, G., Witte, T., Hunzelmann, N., Kreuter, A., Distler, J.H.W., Koeleman, B.P., Voskuyl, A.E., Schuerwegh, A.J., Palm, O., Hesselstrand, R., Nordin, A., Airo, P., Lunardi, C., Scorza, R., Shiels, P., Laar, J.M. van, Herrick, A., Worthington, J., Denton, C., Tan, F.K., Arnett, F.C., Agarwal, S.K., Assassi, S., Fonseca, C., Mayes, M.D., Radstake, T.R.D.J., Martin, J., Spanish Scleroderma Grp, Rheumatology, and CCA - Immuno-pathogenesis
- Subjects
medicine.medical_specialty ,SNP ,Single-nucleotide polymorphism ,Genome-wide association study ,Locus (genetics) ,Systemic Sclerosis ,Biology ,Polymorphism, Single Nucleotide ,White People ,Genetics ,medicine ,Humans ,GWAS ,Genetic Predisposition to Disease ,Genomic disorders and inherited multi-system disorders Molecular epidemiology [IGMD 3] ,Molecular Biology ,Genetics (clinical) ,Genetic association ,Scleroderma, Systemic ,Association Studies Articles ,Receptors, Interleukin-12 ,General Medicine ,Odds ratio ,Infection and autoimmunity Auto-immunity, transplantation and immunotherapy [NCMLS 1] ,United States ,Europe ,Cohort ,Evaluation of complex medical interventions Auto-immunity, transplantation and immunotherapy [NCEBP 2] ,Medical genetics ,Follow-Up Studies ,Genome-Wide Association Study - Abstract
A single-nucleotide polymorphism (SNP) at the IL12RB2 locus showed a suggestive association signal in a previously published genome-wide association study (GWAS) in systemic sclerosis (SSc). Aiming to reveal the possible implication of the IL12RB2 gene in SSc, we conducted a follow-up study of this locus in different Caucasian cohorts. We analyzed 10 GWAS-genotyped SNPs in the IL12RB2 region (2309 SSc patients and 5161 controls). We then selected three SNPs (rs3790567, rs3790566 and rs924080) based on their significance level in the GWAS, for follow-up in an independent European cohort comprising 3344 SSc and 3848 controls. The most-associated SNP (rs3790567) was further tested in an independent cohort comprising 597 SSc patients and 1139 controls from the USA. After conditional logistic regression analysis of the GWAS data, we selected rs3790567 [PMH5 1.92 3 10 -5 odds ratio (OR) 5 1.19] as the genetic variant with the firmest independent association observed in the analyzedGWASpeak of association. After the first follow-up phase, only the association of rs3790567 was consistent (PMH5 4.84 3 10 -3OR 5 1.12). The second follow-up phase confirmed this finding (Px2 5 2.82 3 10 -4 OR 5 1.34). After performing overall pooled-analysis of all the cohorts included in the present study, the association found for the rs3790567 SNP in the IL12RB2 gene region reached GWAS-level significant association (PMH5 2.82 3 10 -9 OR 5 1.17). Our data clearly support the IL12RB2 genetic association with SSc, and suggest a relevant role of the interleukin 12 signaling pathway in SSc pathogenesis. © The Author 2011. Published by Oxford University Press. All rights reserved.
- Published
- 2012
- Full Text
- View/download PDF
9. Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis
- Author
-
Cenit, M.C., Simeon, C.P., Vonk, M.C., Callejas-Rubio, J.L., Espinosa, G., Carreira, P., Blanco, F.J., Narvaez, J., Tolosa, C., Roman-Ivorra, J.A., Gomez-Garcia, I., Garcia-Hernandez, F.J., Gallego, M., Garcia-Portales, R., Egurbide, M.V., Fonollosa, V., Garcia de la Pena, P., Lopez-Longo, F.J., Gonzalez-Gay, M.A., The Spanish Scleroderma, G., Hesselstrand, R., Riemekasten, G., Witte, T.J.M. de, Voskuyl, A.E., Schuerwegh, A.J., Madhok, R., Fonseca, C., Denton, C., Nordin, A., Palm, O., Laar, J.M. van, Hunzelmann, N., Distler, J.H., Kreuter, A., Herrick, A., Worthington, J., Koeleman, B.P., Radstake, T.R.D.J., Martin, J., Rheumatology, and CCA - Innovative therapy
- Subjects
Male ,Immunology ,Disease ,Polymorphism, Single Nucleotide ,White People ,symbols.namesake ,Rheumatology ,medicine ,Humans ,Immunology and Allergy ,SNP ,Genetic Predisposition to Disease ,Allele ,Interleukin 6 ,skin and connective tissue diseases ,Autoimmune disease ,Scleroderma, Systemic ,biology ,Interleukin-6 ,business.industry ,medicine.disease ,Infection and autoimmunity Auto-immunity, transplantation and immunotherapy [NCMLS 1] ,Europe ,Minor allele frequency ,Bonferroni correction ,Meta-analysis ,Disease Progression ,symbols ,biology.protein ,Evaluation of complex medical interventions Auto-immunity, transplantation and immunotherapy [NCEBP 2] ,Female ,business - Abstract
Objective.Systemic sclerosis (SSc) is a genetically complex autoimmune disease; the genetic component has not been fully defined. Interleukin 6 (IL-6) plays a crucial role in immunity and fibrosis, both key aspects of SSc. We investigated the influence of IL6 gene in the susceptibility and phenotype expression of SSc.Methods.We performed a large metaanalysis including a total of 2749 cases and 3189 controls from 6 white populations (Germany, The Netherlands, Norway, Spain, Sweden, and United Kingdom). Three IL6 single-nucleotide polymorphisms (SNP; rs2069827, rs1800795, and rs2069840) were selected by SNP tagging and genotyped using TaqMan® allele discrimination technology.Results.Individual SNP metaanalysis showed no evidence of association of the 3 IL6 genetic variants with the global disease. Phenotype analyses revealed a significant association between the minor allele of rs2069840 and the limited cutaneous SSc clinical form (Bonferroni p = 0.036, OR 1.14, 95% CI 1.04–1.25). A trend of association between the minor allele of the rs1800795 and the diffuse cutaneous SSc clinical form was also evident (Bonferroni p = 0.072, OR 0.86, 95% CI 0.77–0.96). In the IL6 allelic combination analyses, the GGC allelic combination rs2069827-rs1800795-rs2069840 showed an association with overall SSc (Bonferroni p = 0.016, OR 1.13, 95% CI 1.04–1.23).Conclusion.Our results suggest that the IL6 gene may influence the development of SSc and its progression.
- Published
- 2012
- Full Text
- View/download PDF
10. Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
- Author
-
Gorlova, O., Martin, J.E., Rueda, B., Koeleman, B.P.C., Ying, J., Teruel, M., Diaz-Gallo, L.M., Broen, J.C., Vonk, M.C., Simeon, C.P., Alizadeh, B.Z., Coenen, M.J.H., Voskuyl, A.E., Schuerwegh, A.J., Riel, P.L.C.M. van, Vanthuyne, M., van't Slot, R., Italiaander, A., Ophoff, R.A., Hunzelmann, N., Fonollosa, V., Ortego-Centeno, N., Gonzalez-Gay, M.A., Garcia-Hernandez, F.J., Gonzalez-Escribano, M.F., Airo, P., Laar, J. van, Worthington, J., Hesselstrand, R., Smith, V., Keyser, F. de, Houssiau, F., Chee, M.M., Madhok, R., Shiels, P.G., Westhovens, R., Kreuter, A., Baere, E. de, Witte, T., Padyukov, L., Nordin, A., Scorza, R., Lunardi, C., Lie, B.A., Hoffmann-Vold, A.M., Palm, O., Pena, P.G. de la, Carreira, P., Varga, J., Hinchcliff, M., Lee, A.T., Gourh, P., Amos, C.I., Wigley, F.M., Hummers, L.K., Hummers, J., Nelson, J.L., Riemekasten, G., Herrick, A., Beretta, L., Fonseca, C., Denton, C.P., Gregersen, P.K., Agarwal, S., Assassi, S., Tan, F.K., Arnett, F.C., Radstake, T.R.D.J., Mayes, M.D., Martin, J., Spanish Scleroderma Grp, Rheumatology, Human genetics, CCA - Disease profiling, Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI), Life Course Epidemiology (LCE), UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales, UCL - (SLuc) Service de rhumatologie, UCL - (MGD) Service de rhumatologie, and McCarthy, Mark I
- Subjects
Oncology ,Male ,Cancer Research ,systemic sclerosis ,Genome-wide association study ,SUSCEPTIBILITY ,FUNCTIONAL POLYMORPHISM ,Genètica mèdica ,STAT4 ,0302 clinical medicine ,HLA Antigens ,SCLERODERMA ,IRF5 ,2.1 Biological and endogenous factors ,Aetiology ,skin and connective tissue diseases ,Genetics (clinical) ,Genetics ,0303 health sciences ,Medical genetics ,Translational research Immune Regulation [ONCOL 3] ,Single Nucleotide ,Middle Aged ,Infection and autoimmunity Auto-immunity, transplantation and immunotherapy [NCMLS 1] ,3. Good health ,Phenotype ,genome-wide association study ,Evaluation of complex medical interventions Auto-immunity, transplantation and immunotherapy [NCEBP 2] ,Medicine ,ALOPECIA-AREATA ,Female ,Research Article ,Genetic Markers ,medicine.medical_specialty ,Spanish Scleroderma Group ,lcsh:QH426-470 ,functional polymorphism japanese population pulmonary-fibrosis signaling pathways alopecia-areata risk-factor susceptibility scleroderma stat4 irf5 ,Single-nucleotide polymorphism ,Locus (genetics) ,Human leukocyte antigen ,Biology ,Autoimmune Disease ,Polymorphism, Single Nucleotide ,SIGNALING PATHWAYS ,03 medical and health sciences ,Clinical Research ,RISK-FACTOR ,Internal medicine ,medicine ,Genetic predisposition ,Humans ,Genetic Predisposition to Disease ,JAPANESE POPULATION ,Allele ,Polymorphism ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Alleles ,030304 developmental biology ,Autoantibodies ,Rheumatology and Autoimmunity ,030203 arthritis & rheumatology ,Scleroderma, Systemic ,PULMONARY-FIBROSIS ,Inflammatory and immune system ,Systemic ,Human Genome ,Biology and Life Sciences ,lcsh:Genetics ,Meta-analysis ,Scleroderma (Disease) ,Genetic marker ,Genetic Loci ,Clinical Immunology ,Esclerodèrmia ,Metaanàlisi ,Developmental Biology ,Genome-Wide Association Study - Abstract
The aim of this study was to determine, through a genome-wide association study (GWAS), the genetic components contributing to different clinical sub-phenotypes of systemic sclerosis (SSc). We considered limited (lcSSc) and diffuse (dcSSc) cutaneous involvement, and the relationships with presence of the SSc-specific auto-antibodies, anti-centromere (ACA), and anti-topoisomerase I (ATA). Four GWAS cohorts, comprising 2,296 SSc patients and 5,171 healthy controls, were meta-analyzed looking for associations in the selected subgroups. Eighteen polymorphisms were further tested in nine independent cohorts comprising an additional 3,175 SSc patients and 4,971 controls. Conditional analysis for associated SNPs in the HLA region was performed to explore their independent association in antibody subgroups. Overall analysis showed that non-HLA polymorphism rs11642873 in IRF8 gene to be associated at GWAS level with lcSSc (P = 2.32×10−12, OR = 0.75). Also, rs12540874 in GRB10 gene (P = 1.27 × 10−6, OR = 1.15) and rs11047102 in SOX5 gene (P = 1.39×10−7, OR = 1.36) showed a suggestive association with lcSSc and ACA subgroups respectively. In the HLA region, we observed highly associated allelic combinations in the HLA-DQB1 locus with ACA (P = 1.79×10−61, OR = 2.48), in the HLA-DPA1/B1 loci with ATA (P = 4.57×10−76, OR = 8.84), and in NOTCH4 with ACA P = 8.84×10−21, OR = 0.55) and ATA (P = 1.14×10−8, OR = 0.54). We have identified three new non-HLA genes (IRF8, GRB10, and SOX5) associated with SSc clinical and auto-antibody subgroups. Within the HLA region, HLA-DQB1, HLA-DPA1/B1, and NOTCH4 associations with SSc are likely confined to specific auto-antibodies. These data emphasize the differential genetic components of subphenotypes of SSc., Author Summary Scleroderma or systemic sclerosis is a complex autoimmune disease affecting one individual of every 100,000 in Caucasian populations. Even though current genetic studies have led to better understanding of the pathogenesis of the disease, much remains unknown. Scleroderma is a heterogeneous disease, which can be subdivided according to different criteria, such as the involvement of organs and the presence of specific autoantibodies. Such subgroups present more homogeneous genetic groups, and some genetic associations with these manifestations have already been described. Through reanalysis of a genome-wide association study data, we identify three novel genes containing genetic variations which predispose to subphenotypes of the disease (IRF8, GRB10, and SOX5). Also, we better characterize the patterns of associated loci found in the HLA region. Together, our findings lead to a better understanding of the genetic component of scleroderma.
- Published
- 2011
- Full Text
- View/download PDF
11. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
- Author
-
Bossini-Castillo, L., Broen, J.C.A., Simeon, C.P., Beretta, L., Vonk, M.C., Ortego-Centeno, N., Espinosa, G., Carreira, P., Camps, M.T., Navarrete, N., Gonzalez-Escribano, M.F., Vicente-Rabaneda, E., Rodriguez, L., Tolosa, C., Roman-Ivorra, J.A., Gomez-Gracia, I., Garcia-Hernandez, F.J., Castellvi, I., Gallego, M., Fernandez-Nebro, A., Garcia-Portales, R., Egurbide, M.V., Fonollosa, V., Pena, P.G. de la, Pros, A., Gonzalez-Gay, M.A., Hesselstrand, R., Riemekasten, G., Witte, T.J.M. de, Coenen, M.J.H., Koeleman, B.P., Houssiau, F., Smith, V., Keyser, F. de, Westhovens, R., Langhe, E. De, Voskuyl, A.E., Schuerwegh, A.J., Chee, M.M., Madhok, R., Shiels, P., Fonseca, C., Denton, C., Claes, K., Padykov, L., Nordin, A., Palm, O., Lie, B.A., Airo, P., Scorza, R., Laar, J.M. van, Hunzelmann, N., Kreuter, A., Herrick, A., Worthington, J., Radstake, T.R.D.J., Martin, J., Rueda, B., Bossini-Castillo, L., Broen, J.C.A., Simeon, C.P., Beretta, L., Vonk, M.C., Ortego-Centeno, N., Espinosa, G., Carreira, P., Camps, M.T., Navarrete, N., Gonzalez-Escribano, M.F., Vicente-Rabaneda, E., Rodriguez, L., Tolosa, C., Roman-Ivorra, J.A., Gomez-Gracia, I., Garcia-Hernandez, F.J., Castellvi, I., Gallego, M., Fernandez-Nebro, A., Garcia-Portales, R., Egurbide, M.V., Fonollosa, V., Pena, P.G. de la, Pros, A., Gonzalez-Gay, M.A., Hesselstrand, R., Riemekasten, G., Witte, T.J.M. de, Coenen, M.J.H., Koeleman, B.P., Houssiau, F., Smith, V., Keyser, F. de, Westhovens, R., Langhe, E. De, Voskuyl, A.E., Schuerwegh, A.J., Chee, M.M., Madhok, R., Shiels, P., Fonseca, C., Denton, C., Claes, K., Padykov, L., Nordin, A., Palm, O., Lie, B.A., Airo, P., Scorza, R., Laar, J.M. van, Hunzelmann, N., Kreuter, A., Herrick, A., Worthington, J., Radstake, T.R.D.J., Martin, J., and Rueda, B.
- Abstract
Contains fulltext : 96595.pdf (publisher's version ) (Closed access), OBJECTIVES: The aim of this study was to confirm the influence of TNFSF4 polymorphisms on systemic sclerosis (SSc) susceptibility and phenotypic features. METHODS: A total of 8 European populations of Caucasian ancestry were included, comprising 3014 patients with SSc and 3125 healthy controls. Four genetic variants of TNFSF4 gene promoter (rs1234314, rs844644, rs844648 and rs12039904) were selected as genetic markers. RESULTS: A pooled analysis revealed the association of rs1234314 and rs12039904 polymorphisms with SSc (OR 1.15, 95% CI 1.02 to 1.31; OR 1.18, 95% CI 1.08 to 1.29, respectively). Significant association of the four tested variants with patients with limited cutaneous SSc (lcSSc) was revealed (rs1234314 OR 1.22, 95% CI 1.07 to 1.38; rs844644 OR 0.91, 95% CI 0.83 to 0.99; rs844648 OR 1.10, 95% CI 1.01 to 1.20 and rs12039904 OR 1.20, 95% CI 1.09 to 1.33). Association of rs1234314, rs844648 and rs12039904 minor alleles with patients positive for anti-centromere antibodies (ACA) remained significant (OR 1.23, 95% CI 1.10 to 1.37; OR 1.12, 95% CI 1.01 to 1.25; OR 1.22, 95% CI 1.07 to 1.38, respectively). Haplotype analysis confirmed a protective haplotype associated with SSc, lcSSc and ACA positive subgroups (OR 0.88, 95% CI 0.82 to 0.96; OR 0.88, 95% CI 0.80 to 0.96; OR 0.86, 95% CI 0.77 to 0.97, respectively) and revealed a new risk haplotype associated with the same groups of patients (OR 1.14, 95% CI 1.03 to 1.26; OR 1.20, 95% CI 1.08 to 1.35; OR 1.23, 95% CI 1.07 to 1.42, respectively). CONCLUSIONS: The data confirm the influence of TNFSF4 polymorphisms in SSc genetic susceptibility, especially in subsets of patients positive for lcSSc and ACA.
- Published
- 2011
12. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis
- Author
-
Carmona, F.D., Simeon, C.P., Beretta, L., Carreira, P., Vonk, M.C., Rios-Fernandez, R., Espinosa, G., Navarrete, N., Vicente-Rabaneda, E., Rodriguez-Rodriguez, L., Tolosa, C., Garcia-Hernandez, F.J., Castellvi, I., Egurbide, M.V., Fonollosa, V., Gonzalez-Gay, M.A., Rodriguez-Carballeira, M., Diaz-Gonzalez, F., Saez-Comet, L., Hesselstrand, R., Riemekasten, G., Witte, T.J.M. de, Voskuyl, A.E., Schuerwegh, A.J., Madhok, R., Shiels, P., Fonseca, C., Denton, C., Nordin, A., Palm, O., Hoffmann-Vold, A.M., Airo, P., Scorza, R., Lunardi, C., Laar, J.M. van, Hunzelmann, N., Kreuter, A., Herrick, A., Worthington, J., Koeleman, B.P., Radstake, T.R.D.J., Martin, J., Carmona, F.D., Simeon, C.P., Beretta, L., Carreira, P., Vonk, M.C., Rios-Fernandez, R., Espinosa, G., Navarrete, N., Vicente-Rabaneda, E., Rodriguez-Rodriguez, L., Tolosa, C., Garcia-Hernandez, F.J., Castellvi, I., Egurbide, M.V., Fonollosa, V., Gonzalez-Gay, M.A., Rodriguez-Carballeira, M., Diaz-Gonzalez, F., Saez-Comet, L., Hesselstrand, R., Riemekasten, G., Witte, T.J.M. de, Voskuyl, A.E., Schuerwegh, A.J., Madhok, R., Shiels, P., Fonseca, C., Denton, C., Nordin, A., Palm, O., Hoffmann-Vold, A.M., Airo, P., Scorza, R., Lunardi, C., Laar, J.M. van, Hunzelmann, N., Kreuter, A., Herrick, A., Worthington, J., Koeleman, B.P., Radstake, T.R.D.J., and Martin, J.
- Abstract
Contains fulltext : 97656.pdf (publisher's version ) (Closed access)
- Published
- 2011
13. Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature
- Author
-
Gunnarsson, R., primary, Andreassen, A. K., additional, Molberg, O., additional, Lexberg, A. S., additional, Time, K., additional, Dhainaut, A. S. S., additional, Bertelsen, L.-T., additional, Palm, O., additional, Irgens, K., additional, Becker-Merok, A., additional, Nordeide, J. L., additional, Johnsen, V., additional, Pedersen, S., additional, Proven, A., additional, Garabet, L. S. N., additional, Garen, T., additional, Aalokken, T. M., additional, Gilboe, I.-M., additional, and Gran, J. T., additional
- Published
- 2013
- Full Text
- View/download PDF
14. Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality--a retrospective study based on registry data
- Author
-
Palm, O., primary, Garen, T., additional, Berge Enger, T., additional, Jensen, J. L., additional, Lund, M.-B., additional, Aalokken, T. M., additional, and Gran, J. T., additional
- Published
- 2012
- Full Text
- View/download PDF
15. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis
- Author
-
Carmona, F. D., primary, Simeon, C. P., additional, Beretta, L., additional, Carreira, P., additional, Vonk, M. C., additional, Rios-Fernandez, R., additional, Espinosa, G., additional, Navarrete, N., additional, Vicente-Rabaneda, E., additional, Rodriguez-Rodriguez, L., additional, Tolosa, C., additional, Garcia-Hernandez, F. J., additional, Castellvi, I., additional, Egurbide, M. V., additional, Fonollosa, V., additional, Gonzalez-Gay, M. A., additional, Rodriguez-Carballeira, M., additional, Diaz-Gonzalez, F., additional, Saez-Comet, L., additional, Hesselstrand, R., additional, Riemekasten, G., additional, Witte, T., additional, Voskuyl, A. E., additional, Schuerwegh, A. J., additional, Madhok, R., additional, Shiels, P., additional, Fonseca, C., additional, Denton, C., additional, Nordin, A., additional, Palm, O., additional, Hoffmann-Vold, A.-M., additional, Airo, P., additional, Scorza, R., additional, Lunardi, C., additional, van Laar, J. M., additional, Hunzelmann, N., additional, Kreuter, A., additional, Herrick, A., additional, Worthington, J., additional, Koeleman, B. P. C., additional, Radstake, T. R. D. J., additional, and Martin, J., additional
- Published
- 2011
- Full Text
- View/download PDF
16. G.P.3.06 A patient with two mitochondrial DNA mutations causing PEO and LHON
- Author
-
Moslemi, A.R., primary, Melberg, A., additional, Palm, O., additional, Raininko, R., additional, Stålberg, E., additional, and Oldfors, A., additional
- Published
- 2008
- Full Text
- View/download PDF
17. Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis
- Author
-
Kvien, T K, primary, Fjeld, E, additional, Slatkowsky-Christensen, B, additional, Nichols, M, additional, Zhang, Y, additional, Proven, A, additional, Mikkelsen, K, additional, Palm, O, additional, Borisy, A A, additional, and Lessem, J, additional
- Published
- 2007
- Full Text
- View/download PDF
18. Women with early rheumatoid arthritis are referred later than men
- Author
-
Palm, O, primary
- Published
- 2005
- Full Text
- View/download PDF
19. A collection and treatment system for organic waste and wastewater in a sensitive rural area
- Author
-
Malmén, L., primary, Palm, O., additional, and Norin, E., additional
- Published
- 2004
- Full Text
- View/download PDF
20. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study)
- Author
-
Palm, O., primary
- Published
- 2001
- Full Text
- View/download PDF
21. A collection and treatment system for organic waste and wastewater in a sensitive rural area.
- Author
-
Malmén, L., Palm, O., and Norin, E.
- Subjects
- *
SEWAGE disposal pilot plants , *COMPOSTING , *GRAYWATER (Domestic wastewater) , *WASTE recycling , *ORGANIC wastes , *SANITARY engineering , *FERTILIZERS , *RURAL geography , *THERMOPHILIC microorganisms - Abstract
In the municipality of Sund, located in a sensitive rural area in Åland, a demonstration project is now carried out with the overall objective to move the most concentrated fractions of wastewater from the coastal area to a treatment plant situated close to arable land. Blackwater and greywater septic sludge from about twenty households and two tourist camps are treated together with energy rich organic material from a nearby potato-chip factory. The collection concept is based on the use of extremely efficient water-saving toilets, with separate systems for the blackwater and greywater in the households. The collected materials are co-treated in a batchwise aerobic thermophilic treatment process (wet composting process), where the materials reach at least 55°C during a minimum of 10 hours. The dry matter content of the collected material was about 2%. After stabilisation and sanitation (by the temperature rise caused by microbial activity during the treatment process), the compost slurry is utilized as a liquid organic fertilizer on arable land. [ABSTRACT FROM AUTHOR]
- Published
- 2003
22. Femoxetine in the treatment of patients with depressive illness-a randomized comparison with amitriptyline.
- Author
-
Ahlberg, B., Palm, O., and Honor, P. Fevre
- Published
- 1982
- Full Text
- View/download PDF
23. Fibromyalgia and chronic widespread pain in patients with inflammatory bowel disease: a cross sectional population survey.
- Author
-
Palm, O, Moum, B, Jahnsen, J, and Gran, J T
- Abstract
OBJECTIVE: To assess the prevalence of fibromyalgia (FM) and chronic widespread pain (CWP) in a population based cohort of patients with inflammatory bowel disease (IBD). METHODS: Patients in a prospective survey on newly diagnosed IBD were, 5 years after study entry, invited to a clinical examination including the investigation of musculoskeletal manifestations. A total of 521 patients were examined, corresponding to 80% of surviving cases with definite diagnoses of ulcerative colitis (UC) and Crohn's disease (CD). The diagnoses of FM and CWP strictly followed the American College of Rheumatology classification criteria of 1990. RESULTS: At clinical examination, FM was diagnosed in 18 patients (3.5%), 3.7% with UC and 3.0% with CD. The prevalence was 6.4% in females and 0.4% in males. Thirty-eight patients (7.3%) had CWP (8.5% with UC; 4.8% with CD). The female:male ratio was 27:3 in the UC group and 8:0 in CD. In 19 patients (50%), CWP occurred after onset of IBD. No correlation with the extent of intestinal inflammation and the occurrence of FM and CWP was found. CONCLUSION: The prevalences of FM and CWP in patients with IBD were similar to those of the general population. There were no differences in prevalence of FM and CWP between UC and CD. Chronic idiopathic inflammation of the intestine does not appear to predispose to chronic widespread pain.
- Published
- 2001
24. P138 ARE THERE OTHER FACTORS EXPLAINING WHY UC-PATIENTS WITH NORMAL COLONOSCOPY STILL REPORT IBD-RELATED SYMPTOMS?
- Author
-
Bernklev, T., Henriksen, M., Jahnsen, J., Palm, Ø., Vatn, M., and Moum, B.
- Published
- 2007
- Full Text
- View/download PDF
25. P306 THE EFFICACY AND SAFETY OF CRX-102 -A NOVEL SYNCRETIC DRUG CANDIDATE -IN HAND OSTEOARTHRITIS (HOA): RESULTSFROM A PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL (RCT)
- Author
-
Kvien, T.K., Slatkowsky-Christensen, B., Fjeld, E., Prøven, A., Palm, Ø., Mikkelsen, K., Anderson, J., Zhang, Y., Nichols, M., and Lessem, J.
- Published
- 2006
- Full Text
- View/download PDF
26. P217 THE RESPONSIVENESS OF JOINT COUNTS AND PATIENT-REPORTED MEASURES IN HAND OSTEOARTHRITIS (HOA): ANALYSES FROM A PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL (RCT)
- Author
-
Kvien, T.K., Slatkowsky-Christensen, B., Fjeld, E., Prøven, A., Mikkelsen, K., Palm, Ø., Anderson, J., Zhang, Y., Nichols, M., and Lessem, J.
- Published
- 2006
- Full Text
- View/download PDF
27. Influence of the IL17A locus in giant cell arteritis susceptibility
- Author
-
Márquez, A., Hernández Rodríguez, José, Cid Xutglà, M. Cinta, Solans, Roser, Castañeda, Santos, Fernández-Contreras, M. E., Ramentol, Marc, Morado, Inmaculada C., Narváez García, Francisco Javier, Gómez Vaquero, Carmen, Martínez-Taboada, V. M., Ortego Centeno, Norberto, Sopeña, Bernardo, Monfort, J., García-Villanueva, María Jesús, Caminal Montero, L., Miguel, E. de, Blanco, Ricardo, Spanish GCA Consortium, Palm, O., Molberg, O, Latus, J., Braun, Niko, Moosig, F., Witte, Torsten, Beretta, Lorenzo, Santaniello, Alessandro, Pazzola, Giulia, Boiardi, Luigi, Salvarani, Carlo, González-Gay, Miguel A., Martín, Javier, and Universitat de Barcelona
- Subjects
Genotype ,Immunology ,Giant Cell Arteritis ,Locus (genetics) ,Biology ,Genetic polymorphisms ,General Biochemistry, Genetics and Molecular Biology ,Rheumatology ,Gene Frequency ,medicine ,Genetics ,Immunology and Allergy ,Humans ,Genetic Predisposition to Disease ,Arteritis ,Allele ,Allele frequency ,Arteritis de cèl·lules gegants ,Giant cell arteritis ,Polymorphism, Genetic ,Polimorfisme genètic ,Haplotype ,Interleukin-17 ,medicine.disease ,Meta-analysis ,Haplotypes ,Case-Control Studies ,Gene polymorphism ,Vasculitis ,Cytokines ,Gene Polymorphism ,Genètica ,Metaanàlisi - Abstract
Objective Different lines of evidence have highlighted the role of IL-17A in the inflammatory process occurring in giant cell arteritis (GCA). The aim of the present study was to assess whether the IL17A locus influences GCA susceptibility and its clinical subphenotypes. Methods We carried out a large meta-analysis including a total of 1266 biopsy-proven GCA patients and 3779 healthy controls from four European populations (Spain, Italy, Germany and Norway). Five IL17A polymorphisms (rs4711998, rs8193036, rs3819024, rs2275913 and rs7747909) were selected by tagging and genotyped using TaqMan assays. Allelic combination and dependency tests were also performed. Results In the pooled analysis, two of the five analysed polymorphisms showed evidence of association with GCA (rs2275913: P MH =1.85E−03, OR=1.17 (1.06–1.29); rs7747909: P MH =8.49E–03, OR=1.15 (1.04–1.27)). A clear trend of association was also found for the rs4711998 variant (P MH =0.059, OR=1.11 (1.00–1.23)). An independent effect of rs2275913 and rs4711998 was evident by conditional regression analysis. In addition, the haplotype harbouring the risk alleles better explained the observed association than the polymorphisms independently (likelihood p value −05 ). Conclusions Polymorphisms within the IL17A locus show a novel association with GCA. This finding supports the relevant role of the Th17 cells in this vasculitis pathophysiology.
28. Management and environmental constraints to rice yield within a village irrigation system ? A case study from Sri Lanka
- Author
-
Dal�us, E., primary, Palm, O., additional, Sandell, K., additional, Jayawardena, S.N., additional, and Siripala, G.D., additional
- Published
- 1988
- Full Text
- View/download PDF
29. Sustainable agriculture and nitrogen supply in Sri Lanka: farmers' and scientists' perspective
- Author
-
Palm, O. and Sandell, K.
- Subjects
- *
NITROGEN , *SUSTAINABLE agriculture - Published
- 1989
30. Nitrogen mineralization of Sesbania sesban used as green manure for lowland rice in Sri Lanka
- Author
-
de Silva, M. A. P., Palm, O., Rosswall, T., and Weerakoon, W. L.
- Subjects
MANURES ,NITROGEN - Published
- 1988
31. Spleen contraction elevates hemoglobin concentration at high altitude during rest and exercise.
- Author
-
Schagatay E, Lunde A, Nilsson S, Palm O, and Lodin-Sundström A
- Subjects
- Acclimatization physiology, Adult, Altitude, Exercise Test methods, Female, Heart Rate physiology, Humans, Hypoxia metabolism, Hypoxia physiopathology, Male, Oxygen metabolism, Oxygen Consumption physiology, Ultrasonography methods, Exercise physiology, Hemoglobins metabolism, Rest physiology, Spleen metabolism
- Abstract
Purpose: Hypoxia and exercise are known to separately trigger spleen contraction, leading to release of stored erythrocytes. We studied spleen volume and hemoglobin concentration (Hb) during rest and exercise at three altitudes., Methods: Eleven healthy lowlanders did a 5-min modified Harvard step test at 1370, 3700 and 4200 m altitude. Spleen volume was measured via ultrasonic imaging and capillary Hb with Hemocue during rest and after the step test, and arterial oxygen saturation (SaO
2 ), heart rate (HR), expiratory CO2 (ETCO2 ) and respiratory rate (RR) across the test., Results: Resting spleen volume was reduced with increasing altitude and further reduced with exercise at all altitudes. Mean (SE) baseline spleen volume at 1370 m was 252 (20) mL and after exercise, it was 199 (15) mL (P < 0.01). At 3700 m, baseline spleen volume was 231 (22) mL and after exercise 166 (12) mL (P < 0.05). At 4200 m baseline volume was 210 (23) mL and after exercise 172 (20) mL (P < 0.05). After 10 min, spleen volume increased to baseline at all altitudes (NS). Baseline Hb increased with altitude from 138.9 (6.1) g/L at 1370 m, to 141.2 (4.1) at 3700 m and 152.4 (4.0) at 4200 m (P < 0.01). At all altitudes Hb increased from baseline during exercise to 146.8 (5.7) g/L at 1370 m, 150.4 (3.8) g/L at 3700 m and 157.3 (3.8) g/L at 4200 m (all P < 0.05 from baseline). Hb had returned to baseline after 10 min rest at all altitudes (NS). The spleen-derived Hb elevation during exercise was smaller at 4200 m compared to 3700 m (P < 0.05). Cardiorespiratory variables were also affected by altitude during both rest and exercise., Conclusions: The spleen contracts and mobilizes stored red blood cells during rest at high altitude and contracts further during exercise, to increase oxygen delivery to tissues during acute hypoxia. The attenuated Hb response to exercise at the highest altitude is likely due to the greater recruitment of the spleen reserve during rest, and that maximal spleen contraction is reached with exercise.- Published
- 2020
- Full Text
- View/download PDF
32. Characterization of motility and piliation in pathogenic Neisseria.
- Author
-
Eriksson J, Eriksson OS, Maudsdotter L, Palm O, Engman J, Sarkissian T, Aro H, Wallin M, and Jonsson AB
- Subjects
- Base Sequence, Conserved Sequence, Fimbriae Proteins metabolism, Fimbriae, Bacterial metabolism, Mutation, Promoter Regions, Genetic, Species Specificity, Fimbriae Proteins genetics, Fimbriae, Bacterial genetics, Neisseria gonorrhoeae physiology, Neisseria meningitidis physiology
- Abstract
Background: The type IV pili (Tfp) of pathogenic Neisseria (i.e., N. gonorrhoeae and N. meningitidis) are essential for twitching motility. Tfp retraction, which is dependent on the ATPase PilT, generates the forces that move bacteria over surfaces. Neisseria motility has mainly been studied in N. gonorrhoeae whereas the motility of N. meningitidis has not yet been characterized., Results: In this work, we analyzed bacterial motility and monitored Tfp retraction using live-cell imaging of freely moving bacteria. We observed that N. meningitidis moved over surfaces at an approximate speed of 1.6 μm/s, whereas N. gonorrhoeae moved with a lower speed (1.0 μm/s). An alignment of the meningococcal and gonococcal pilT promoters revealed a conserved single base pair variation in the -10 promoter element that influence PilT expression. By tracking mutants with altered pilT expression or pilE sequence, we concluded that the difference in motility speed was independent of both. Live-cell imaging using total internal reflection fluorescence microscopy demonstrated that N. gonorrhoeae more often moved with fewer visible retracting filaments when compared to N. meningitidis. Correspondingly, meningococci also displayed a higher level of piliation in transmission electron microscopy. Nevertheless, motile gonococci that had the same number of filaments as N. meningitidis still moved with a lower speed., Conclusions: These data reveal differences in both speed and piliation between the pathogenic Neisseria species during twitching motility, suggesting a difference in Tfp-dynamics.
- Published
- 2015
- Full Text
- View/download PDF
33. A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA.
- Author
-
Márquez A, Solans R, Hernández-Rodríguez J, Cid MC, Castañeda S, Ramentol M, Rodriguez-Rodriguez L, Narváez J, Blanco R, Ortego-Centeno N, Palm O, Diamantopoulos AP, Braun N, Moosig F, Witte T, Beretta L, Lunardi C, Cimmino MA, Vaglio A, Salvarani C, González-Gay MA, and Martín J
- Subjects
- Alleles, Case-Control Studies, Cohort Studies, Disease Susceptibility, Female, Gene Regulatory Networks, Genetic Loci, Genotype, Giant Cell Arteritis pathology, Humans, Interleukin-1 Receptor-Like 1 Protein, Male, Odds Ratio, Polymorphism, Single Nucleotide, Receptors, Cell Surface genetics, Risk Factors, Giant Cell Arteritis genetics, Interleukin-33 genetics
- Abstract
Introduction: Increased expression of IL-33 and its receptor ST2, encoded by the IL1RL1 gene, has been detected in the inflamed arteries of giant cell arteritis (GCA) patients. The aim of the present study was to investigate for the first time the potential influence of the IL33 and IL1RL1 loci on GCA predisposition., Methods: A total of 1,363 biopsy-proven GCA patients and 3,908 healthy controls from four European cohorts (Spain, Italy, Germany and Norway) were combined in a meta-analysis. Six genetic variants: rs3939286, rs7025417 and rs7044343, within the IL33 gene, and rs2058660, rs2310173 and rs13015714, within the IL1RL1 gene, previously associated with immune-related diseases, were genotyped using predesigned TaqMan assays., Results: A consistent association between the rs7025417 polymorphism and GCA was evident in the overall meta-analysis, under both allele (P(MH) = 0.041, OR = 0.88, CI 95% 0.78-0.99) and recessive (P(MH) = 3.40E-03, OR = 0.53, CI 95% 0.35-0.80) models. No statistically significant differences between allele or genotype frequencies for the other IL33 and IL1RL1 genetic variants were detected in this pooled analysis., Conclusions: Our results clearly evidenced the implication of the IL33 rs7025417 polymorphism in the genetic network underlying GCA.
- Published
- 2014
- Full Text
- View/download PDF
34. Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality--a retrospective study based on registry data.
- Author
-
Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aaløkken TM, and Gran JT
- Subjects
- Adult, Aged, Aged, 80 and over, Comorbidity, Female, Humans, Lung Diseases mortality, Lung Diseases psychology, Male, Middle Aged, Norway epidemiology, Prevalence, Registries, Respiratory Function Tests, Retrospective Studies, Sjogren's Syndrome mortality, Sjogren's Syndrome psychology, Survival Analysis, Lung Diseases epidemiology, Quality of Life, Sjogren's Syndrome epidemiology
- Abstract
Objective: The aim of the present study was to describe the prevalence of clinical pulmonary manifestations in primary SS (pSS), and based on registry data, to assess quality of life (QoL) and mortality in these patients., Methods: Patients with pSS consecutively included in the Norwegian systemic CTD and vasculitis registry (NOSVAR) were investigated for pulmonary manifestations when presenting with clinical pulmonary symptoms. Pulmonary involvement was defined as typical abnormalities identified with high-resolution CT (HRCT) and/or pulmonary function tests (PFTs)., Results: Among patients referred from our primary area, Oslo (n = 117), lung involvement was found in 26 patients (22%). In our total cohort (n = 216), 59 patients (27%) were affected. A higher rate of pulmonary complications and trends towards longer disease duration and higher age indicated a selection of more complicated cases referred from outside our primary area. Abnormal HRCTs were found in 50 patients (23%) and PFTs in 34 patients (16%). The Medical Outcomes Study 36-Item Short-Form Health Survey Physical Functioning subscore, was significantly reduced in patients with lung involvement (P = 0.03). Furthermore, a 4-fold increased risk of dying after 10 years of disease among patients with lung involvement (n = 10, 17%) compared with those without lung involvement (n = 7, 4.5%) (P = 0.002) was found., Conclusion: We found a high population-based prevalence of clinical pulmonary involvement (22%) among patients with pSS. Moreover, patients with lung involvement had reduced QoL represented by the subscale Physical Functioning, and mortality was increased.
- Published
- 2013
- Full Text
- View/download PDF
35. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study.
- Author
-
Gunnarsson R, Aaløkken TM, Molberg Ø, Lund MB, Mynarek GK, Lexberg AS, Time K, Dhainaut AS, Bertelsen LT, Palm O, Irgens K, Becker-Merok A, Nordeide JL, Johnsen V, Pedersen S, Prøven A, Garabet LS, and Gran JT
- Subjects
- Adult, Cohort Studies, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Lung Diseases, Interstitial pathology, Male, Middle Aged, Mixed Connective Tissue Disease pathology, Motor Activity, Norway epidemiology, Prevalence, Pulmonary Fibrosis mortality, Pulmonary Fibrosis pathology, Pulmonary Fibrosis physiopathology, Lung Diseases, Interstitial mortality, Lung Diseases, Interstitial physiopathology, Mixed Connective Tissue Disease mortality, Mixed Connective Tissue Disease physiopathology, Severity of Illness Index
- Abstract
Background: Mixed connective tissue disease (MCTD) is an immune-mediated, systemic disorder of unknown cause., Objective: To assess the prevalence, pattern and severity of interstitial lung disease (ILD) in a cross-sectional study of the nationwide, Norwegian MCTD cohort., Methods: 126 patients with MCTD were systematically examined for ILD by high-resolution CT (HRCT), pulmonary function tests (PFT), 6 min walk test (6MWT) and by the New York Heart Association (NYHA) functional classification of dyspnoea. The extent and type of HRCT lung abnormalities were scored according to the CT criteria of ILD recommended by the Fleischner Society., Results: All 126 patients were Caucasian, 75% women. At the time of the cross-sectional ILD study, the patients had a mean disease duration of 9.0 years. 52% of the patients had abnormal HRCT findings, most commonly reticular patterns consistent with lung fibrosis (35%). Lung fibrosis was quantified as minor in 7%, moderate in 9% and severe in 19% of the patients. Fibrosis was uniformly concentrated in the lower parts of the lungs and was not associated with smoking. Patients with severe lung fibrosis had lower PFT values, shorter 6MWT and a higher mean NYHA functional class. After a mean 4.2 years' follow-up, overall mortality was 7.9%. Mortality in patients with normal HRCT was 3.3%, as compared with 20.8% in patients with severe lung fibrosis (p<0.01)., Conclusions: Severe lung fibrosis is common in MCTD, has an impact on pulmonary function and overall physical capacity and is associated with increased mortality.
- Published
- 2012
- Full Text
- View/download PDF
36. Prevalence of IgA class antibodies to cyclic citrullinated peptide in patients with inflammatory bowel disease (IBD).
- Author
-
Haga HJ, Palm O, and Peen E
- Subjects
- Adult, Arthritis blood, Arthritis diagnosis, Arthritis immunology, Autoantibodies blood, Cohort Studies, Female, Humans, Immunoglobulin Isotypes immunology, Inflammatory Bowel Diseases diagnosis, Male, Middle Aged, Immunoglobulin A blood, Immunoglobulin Isotypes blood, Inflammatory Bowel Diseases blood, Inflammatory Bowel Diseases immunology, Peptides, Cyclic immunology
- Abstract
Determine the prevalence of anti-CCP isotype IgA and its relation to peripheral arthritis in patients with inflammatory bowel disease (IBD). In a population-based cohort of 654 patients with a definitive diagnosis of IBD, 521 patients were clinically examined by a rheumatologist 6 years after IBD diagnosis Blood serum samples of 416 of these patients were available and analyzed. Antibodies against cyclic citrullinated peptides anti-CCP IgA were determined in the serum samples by an immunofluoresence technique ELiA TM. Among the 416 IBD patients, 5 had a positive IgA class anti-CCP, giving a prevalence of 1.2%. Only four anti-CCP IgA-negative patients had a positive rheumatoid factor IgM, compared to two out of five anti-CCP IgA-positive IBD patients (10.2% versus 40.0%; p = 0.002). There were four patients with rheumatoid arthritis, two in each patient population (0.5% versus 40.0%; p = 0.0007). Four of the five anti-CCP IgA-positive IBD patients had arthritis, two with rheumatoid arthritis, and two with other arthritis. In this first study on the prevalence of IgA anti-CCP antibodies in IBD patients, we demonstrate a low prevalence, but these antibodies are associated with arthritis and positive IgM rheumatoid factor in IBD patients.
- Published
- 2011
- Full Text
- View/download PDF
37. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort.
- Author
-
Bossini-Castillo L, Broen JC, Simeon CP, Beretta L, Vonk MC, Ortego-Centeno N, Espinosa G, Carreira P, Camps MT, Navarrete N, González-Escribano MF, Vicente-Rabaneda E, Rodríguez L, Tolosa C, Román-Ivorra JA, Gómez-Gracia I, García-Hernández FJ, Castellví I, Gallego M, Fernández-Nebro A, García-Portales R, Egurbide MV, Fonollosa V, de la Peña PG, Pros A, González-Gay MA, Hesselstrand R, Riemekasten G, Witte T, Coenen MJ, Koeleman BP, Houssiau F, Smith V, de Keyser F, Westhovens R, De Langhe E, Voskuyl AE, Schuerwegh AJ, Chee MM, Madhok R, Shiels P, Fonseca C, Denton C, Claes K, Padykov L, Nordin A, Palm O, Lie BA, Airó P, Scorza R, van Laar JM, Hunzelmann N, Kreuter A, Herrick A, Worthington J, Radstake TR, Martín J, and Rueda B
- Subjects
- Case-Control Studies, Gene Frequency, Genetic Association Studies, Genetic Predisposition to Disease, Haplotypes, Humans, Promoter Regions, Genetic genetics, OX40 Ligand genetics, Polymorphism, Single Nucleotide, Scleroderma, Systemic genetics
- Abstract
Objectives: The aim of this study was to confirm the influence of TNFSF4 polymorphisms on systemic sclerosis (SSc) susceptibility and phenotypic features., Methods: A total of 8 European populations of Caucasian ancestry were included, comprising 3014 patients with SSc and 3125 healthy controls. Four genetic variants of TNFSF4 gene promoter (rs1234314, rs844644, rs844648 and rs12039904) were selected as genetic markers., Results: A pooled analysis revealed the association of rs1234314 and rs12039904 polymorphisms with SSc (OR 1.15, 95% CI 1.02 to 1.31; OR 1.18, 95% CI 1.08 to 1.29, respectively). Significant association of the four tested variants with patients with limited cutaneous SSc (lcSSc) was revealed (rs1234314 OR 1.22, 95% CI 1.07 to 1.38; rs844644 OR 0.91, 95% CI 0.83 to 0.99; rs844648 OR 1.10, 95% CI 1.01 to 1.20 and rs12039904 OR 1.20, 95% CI 1.09 to 1.33). Association of rs1234314, rs844648 and rs12039904 minor alleles with patients positive for anti-centromere antibodies (ACA) remained significant (OR 1.23, 95% CI 1.10 to 1.37; OR 1.12, 95% CI 1.01 to 1.25; OR 1.22, 95% CI 1.07 to 1.38, respectively). Haplotype analysis confirmed a protective haplotype associated with SSc, lcSSc and ACA positive subgroups (OR 0.88, 95% CI 0.82 to 0.96; OR 0.88, 95% CI 0.80 to 0.96; OR 0.86, 95% CI 0.77 to 0.97, respectively) and revealed a new risk haplotype associated with the same groups of patients (OR 1.14, 95% CI 1.03 to 1.26; OR 1.20, 95% CI 1.08 to 1.35; OR 1.23, 95% CI 1.07 to 1.42, respectively)., Conclusions: The data confirm the influence of TNFSF4 polymorphisms in SSc genetic susceptibility, especially in subsets of patients positive for lcSSc and ACA.
- Published
- 2011
- Full Text
- View/download PDF
38. A patient with two mitochondrial DNA mutations causing PEO and LHON.
- Author
-
Melberg A, Moslemi AR, Palm O, Raininko R, Stålberg E, and Oldfors A
- Subjects
- Electron Transport Complex IV genetics, Humans, Male, Point Mutation, Sequence Deletion, Young Adult, DNA, Mitochondrial genetics, Mitochondrial Myopathies genetics, Mutation, Optic Atrophy, Hereditary, Leber genetics
- Abstract
We report a 22-year-old man with PEO and optic atrophy. PEO developed before the onset of optic atrophy. The patient showed mitochondrial myopathy with cytochrome c oxidase deficient fibers. In skeletal muscle the patient was homoplasmic for the mtDNA G11778A Leber hereditary optic neuropathy (LHON) mutation and heteroplasmic for the mtDNA 5 kb "common" deletion mutation. In blood only the homoplasmic LHON mutation was identified. The occurrence of two pathogenic mtDNA mutations is exceedingly rare. The clinical findings in this patient indicate that the combination of the two mtDNA mutations resulted in the expected combined phenotype since the mtDNA deletion mutation accounted for the PEO and the mtDNA G11778A point mutation for the optic atrophy.
- Published
- 2009
- Full Text
- View/download PDF
39. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study).
- Author
-
Palm O, Moum B, Ongre A, and Gran JT
- Subjects
- Adolescent, Adult, Aged, Arthritis, Psoriatic epidemiology, Arthritis, Reactive epidemiology, Child, Female, Humans, Low Back Pain diagnostic imaging, Low Back Pain epidemiology, Male, Middle Aged, Prevalence, Radiography, Sacroiliac Joint diagnostic imaging, Spondylitis, Ankylosing diagnostic imaging, Colitis, Ulcerative epidemiology, Crohn Disease epidemiology, Spondylitis, Ankylosing epidemiology
- Abstract
Objective: To study the occurrence of spondyloarthropathies (SpA) in patients with inflammatory bowel disease (IBD) seen 6 years after IBD diagnosis., Methods: In a population based cohort of 654 patients with IBD, 521 patients (80%) were investigated, which included a complete rheumatological examination. Radiographs of the sacroiliac joints and lumbar spine were performed in 406 of these patients (78%). The development of SpA was analyzed with regard to the presence of HLA-B27, duration of IBD symptoms, and the extent of intestinal inflammation., Results: The occurrence of ankylosing spondylitis (AS) was 2.6% in ulcerative colitis and 6% in Crohn's disease (p = 0.08), yielding an overall prevalence of 3.7% in IBD. No correlation between localization or extent of the intestinal inflammation and presence of AS was found. HLA-B27 was present in 73% of cases with AS. The overall prevalence of SpA was 22%. Inflammatory back pain without AS (IBP) was found in 18% of the patients. Typical features of SpA were rare, while fibromyalgia was common in IBP, indicating that IBP is not a precursor or manifestation of SpA in patients with IBD. The prevalence of radiological sacroiliitis without clinical features of SpA was 2.0%., Conclusion: AS occurred frequently in patients with newly diagnosed IBD. IBP did not seem to predispose to AS or other forms of SpA. The overall prevalence of SpA was 22%, whereas the prevalence of asymptomatic radiological sacroiliitis was low.
- Published
- 2002
40. [Pelvic pain syndrome in women--a psychiatric-gynaecological study (author's transl)].
- Author
-
Hackl H, Lindström B, Orstam S, Palm O, and Stafsnes H
- Subjects
- Adult, Female, Humans, Middle Aged, Muscle Spasticity complications, Psychophysiologic Disorders complications, Dyspareunia etiology, Pain etiology, Pelvis
- Abstract
77 selected patients suffering from dyspareunia and pelvic pain on moving, with normal findings on gynaecological palpation were submitted to laparoscopy or laparotomy, as well as to a psychiatric investigation. In 25% of the cases no pathological changes were seen--group I; in a further 40% signs of slight--group II--and in the remaining 35% of cases signs of serious pelvic congestion were present--group III. Serious pelvic congestion occurred most frequently between 26 and 35 years of age and seemed to be connected with more than one delivery. Furthermore, in the total material, 65% of patients showed psychologically inadequate personalities whereby nearly 90% of the women in group I, but only a little over 40% in group III, displayed psychological inadequacy, with the women in group II occupying an intermediate position. On the basis of this observation and other investigated personality variables, pelvic pain without pathological findings seems to be caused by neuromuscular spasm in psychologically vulnerable persons. Pelvic pain with different degrees of pelvic congestion cannot be entirely dissociated from the possibility of psychological overlay, which may, however, be of a secondary nature.
- Published
- 1980
41. [Compensation for removals of tattoos].
- Author
-
von Meyburg O, Norberg B, Palm O, and Wikström K
- Subjects
- Economics, Medical, Skin Transplantation, Sweden, State Medicine, Tattooing
- Published
- 1969
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.